Long-term Results of the PRESERFLO MicroShunt in Patients With Primary Open-angle Glaucoma From a Single-center Nonrandomized Study
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Glaucoma"
DOI: 10.1097/ijg.0000000000001734
Abstract: Precis: The MicroShunt was implanted in 23 patients with primary open-angle glaucoma (POAG) in a feasibility study. Reductions in intraocular pressure (IOP) and medications were sustained for up to 5 years with no long-term sight-threatening… read more here.
Keywords: glaucoma; study; year; long term ... See more keywords
Novel Surgical Techniques to Control Flow with PreserFlo® MicroShunt for Late Hypotony After Baerveldt Drainage Device Implantation.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of glaucoma"
DOI: 10.1097/ijg.0000000000002061
Abstract: We report a new surgical technique for controlling flow with a PreserFlo® MicroShunt, in patients with late postoperative hypotony, following a Baerveldt glaucoma drainage device implantation. We present two cases with late postoperative hypotony after… read more here.
Keywords: preserflo microshunt; drainage device; microshunt; baerveldt ... See more keywords
A 2-Year, Single-Center Study to Assess the Safety and Effectiveness of the MicroShunt in Primary Open Angle Glaucoma.
Sign Up to like & getrecommendations! Published in 2022 at "Ophthalmic research"
DOI: 10.1159/000526960
Abstract: AIM To assess the effectiveness and safety of the MicroShunt (formerly known as the MIDI-Arrow or InnFocus MicroShunt®), an 8.5-mm-long, 70-µm lumen controlled ab-externo glaucoma filtration surgery device made from poly(styrene-block-isobutylene-block-styrene) (SIBS), in patients with… read more here.
Keywords: safety; year; glaucoma; microshunt ... See more keywords